Blank Bio is a YC-backed startup focused on building next-generation RNA foundation models that accelerate the development of RNA therapeutics. Their computational toolkit is designed to assist in various applications, including state-of-the-art mRNA property prediction and analyses such as cfRNA decoding, biomarker discovery, and target identification. By translating decades of machine learning research into powerful models, Blank Bio aims to enhance the design and effectiveness of mRNA medicines, collaborating with major industry players like Sanofi and GSK, and partnering with the Arc Institute for advanced initiatives in virtual cell modeling.